My activity
- Last accessed:
- Current status:
-
Course Information
- Title:
- [Retired] Blood 05 - Anti-D Clinical Module
- Description:
- The Anti-D Clinical course covers pathophysiology, management of routine and non-routine care during pregnancy, informed decision making and administration of anti-D immunoglobulin. On completion of the course you will be able to: • Explain the significance of the RhD factor during pregnancy, the pathophysiology of antibody formation following fetomaternal haemorrhage and how anti-D immunoglobulin prevents sensitisation • Describe the impact that anti-D prophylaxis has on maternal, fetal and neonatal outcomes • Discuss the management of potentially sensitising events during pregnancy and the care of women already sensitised to the RhD antigen • Identify national guidance for anti-D prophylaxis • Recognise the need to facilitate informed decision making in relation to anti-D immunoglobulin • Describe the safe storage and administration of anti-D immunoglobulin Learnbloodtransfusion is recommended by: • UK Blood Services • The Serious Hazards of Transfusion Scheme (SHOT) • The National Blood Transfusion Committee (NBTC), England and the respective committees in Northern Ireland, Scotland, Wales and Republic of Ireland
- Hierarchy:
- Blood Transfusion (Blood) > [Retired] Blood 05 - Anti-D Clinical Module
- Keywords:
- blood, administration, risk, benefit, SHOT, BSQR, Blood Safety and Quality Regulations, Serious Hazards of Transfusion, patient identification, blood group, Anti-D, RhD, Rhesus negative, Haemolytic Disease of the Newborn, HDN, feto-maternal haemorrhage, Anti-D immunoglobulin, informed decision making, RAADP, routine antenatal, Potentially Sensitising Event, PSE, Kleihaur test, anti-D, cord blood, learnbloodtransfusion, maternity, midwives, midwifery, maternity support worker, MSW, neonatal
- Created:
- 28 Apr 2011
- Updated:
- 1 Jan 2021
Share this item
- Copy URL
- Title:
- [Retired] Blood 05 - Anti-D Clinical Module
- Description:
- The Anti-D Clinical course covers pathophysiology, management of routine and non-routine care during pregnancy, informed decision making and administration of anti-D immunoglobulin. On completion of the course you will be able to: • Explain the significance of the RhD factor during pregnancy, the pathophysiology of antibody formation following fetomaternal haemorrhage and how anti-D immunoglobulin prevents sensitisation • Describe the impact that anti-D prophylaxis has on maternal, fetal and neonatal outcomes • Discuss the management of potentially sensitising events during pregnancy and the care of women already sensitised to the RhD antigen • Identify national guidance for anti-D prophylaxis • Recognise the need to facilitate informed decision making in relation to anti-D immunoglobulin • Describe the safe storage and administration of anti-D immunoglobulin Learnbloodtransfusion is recommended by: • UK Blood Services • The Serious Hazards of Transfusion Scheme (SHOT) • The National Blood Transfusion Committee (NBTC), England and the respective committees in Northern Ireland, Scotland, Wales and Republic of Ireland
- Hierarchy:
- Blood Transfusion (Blood) > [Retired] Blood 05 - Anti-D Clinical Module
- Keywords:
- blood, administration, risk, benefit, SHOT, BSQR, Blood Safety and Quality Regulations, Serious Hazards of Transfusion, patient identification, blood group, Anti-D, RhD, Rhesus negative, Haemolytic Disease of the Newborn, HDN, feto-maternal haemorrhage, Anti-D immunoglobulin, informed decision making, RAADP, routine antenatal, Potentially Sensitising Event, PSE, Kleihaur test, anti-D, cord blood, learnbloodtransfusion, maternity, midwives, midwifery, maternity support worker, MSW, neonatal
- Created:
- 28 Apr 2011
- Updated:
- 1 Jan 2021